Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

Item

http://www.wikidata.org/entity/Q35740155

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@ast

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@en

type

Item

label

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@ast

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@en

prefLabel

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@ast

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection.

@en

P1476

Pharmacogenomic perspectives of chronic hepatitis C virus (HCV) infection

@en

P2093

Kaslow RA

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon

Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro

The type I interferon receptor: structure, function, and evolution of a family business.

Chronic viral hepatitis and the human genome.

Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.

High body mass index is an independent risk factor for nonresponse to antiviral treatment in chronic hepatitis C.

Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy.

Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group.

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection.

P2888

sj.tpj.6500246

P304

171-174

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.TPJ.6500246

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jianming Tang

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8633086

http://www.w3.org/2001/XMLSchema#string

P698

15069460

http://www.w3.org/2001/XMLSchema#string

P921

pharmacogenomics